SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Siddiqui Sami A.

(Last)

(First)

(Middle)

5707 BLUE LAGOON DRIVE

(Street)

MIAMI

33126

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Restaurant Brands International Inc. [ QSR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Brand Pres., Popeyes, Americas

3. Date of Earliest Transaction (Month/Day/Year)
01/05/2021

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares	01/05/2021		A		117.4344⁽¹⁾	A	$0.00	80,220.7964	D
Common Shares	01/05/2021		S		5,437.6319⁽²⁾	D	$58.95	74,783.1645	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Option (Right to Buy)	$55.55							02/24/2022	02/23/2027	Common Shares	80,000		80,000	D
Option (Right to Buy)	$66.31							02/21/2025	02/20/2030	Common Shares	20,000		20,000	D
Restricted Share Units	⁽³⁾							⁽⁴⁾	⁽⁴⁾	Common Shares	7,771		7,771	D
Dividend Equivalent Rights	⁽⁵⁾	01/05/2021		A		75.7173		⁽⁶⁾	⁽⁶⁾	Common Shares	75.7173	$0.00	952.503	D
Restricted Share Units	⁽³⁾							⁽⁷⁾	⁽⁷⁾	Common Shares	5,726		5,726	D
Dividend Equivalent Rights	⁽⁵⁾	01/05/2021		A		53.3782		⁽⁸⁾	⁽⁸⁾	Common Shares	53.3782	$0.00	423.7949	D
Restricted Share Units	⁽³⁾							⁽⁹⁾	⁽⁹⁾	Common Shares	7,163		7,163	D
Dividend Equivalent Rights	⁽⁵⁾	01/05/2021		A		64.8315		⁽¹⁰⁾	⁽¹⁰⁾	Common Shares	64.8315	$0.00	306.3352	D
Performance Share Units	⁽¹¹⁾							02/26/2021	02/26/2021	Common Shares	151,576.9718		151,576.9718	D
Dividend Equivalent Rights	⁽⁵⁾	01/05/2021		A		1,497.4581		⁽¹²⁾	⁽¹²⁾	Common Shares	1,497.4581	$0.00	20,947.4776	D
Performance Share Units	⁽¹³⁾							02/22/2024	02/22/2024	Common Shares	50,000		50,000	D
Dividend Equivalent Rights	⁽⁵⁾	01/05/2021		A		466.1045		⁽¹⁴⁾	⁽¹⁴⁾	Common Shares	466.1045	$0.00	3,700.6196	D
Performance Share Units	⁽¹⁵⁾							02/21/2025	02/21/2025	Common Shares	20,000		20,000	D
Dividend Equivalent Rights	⁽⁵⁾	01/05/2021		A		181.0177		⁽¹⁶⁾	⁽¹⁶⁾	Common Shares	181.0177	$0.00	855.3266	D
Performance Share Units	⁽¹⁷⁾							02/21/2025	02/21/2025	Common Shares	20,000		20,000	D
Dividend Equivalent Rights	⁽⁵⁾	01/05/2021		A		175.1137		⁽¹⁸⁾	⁽¹⁸⁾	Common Shares	175.1137	$0.00	175.1137	D

Explanation of Responses:

1. Represents shares settled from dividend equivalent rights that accrued on a vested restricted share unit award in respect of dividends that were paid after the vesting of the award with a record date prior to the vesting of the award.

2. Represents shares sold to cover withholding tax obligations on the settlement of the previously reported vesting of the Reporting Person's restricted share units.

3. Each restricted share unit represents a contingent right to receive one common share.

4. These restricted share units vest on December 31, 2021.

5. Each whole dividend equivalent right represents a contingent right to receive one common share.

6. These dividend equivalent rights accrued on the 2017 restricted share unit award (the "2017 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2017 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2017 RSUs to which they relate.

7. These restricted share units vest on December 31, 2023.

8. These dividend equivalent rights accrued on the 2019 restricted share unit award (the "2019 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2019 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2019 RSUs to which they relate.

9. These restricted share units vest on December 31, 2024.

10. These dividend equivalent rights accrued on the 2020 restricted share unit award (the "2020 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2020 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2020 RSUs to which they relate.

11. The shares reported represent an award of performance based restricted share units (the "2016 PBRSUs") granted to the Reporting Person. The 2016 PBRSUs had a three-year performance period beginning January 1, 2016 and ending December 31, 2018 and will vest 100% on February 26, 2021, which is the fifth anniversary of the grant date.

12. These dividend equivalent rights accrued on the 2016 PBRSUs. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 PBRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 PBRSUs to which they relate.

13. The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest 100% on February 22, 2024, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the Issuer performance condition.

14. These dividend equivalent rights accrued on the 2019 PBRSUs. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2019 PBRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2019 PBRSUs to which they relate.

15. The shares reported represent an award of performance based restricted share units (the "2020-1 PBRSUs") granted to the Reporting Person. The 2020-1 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest 100% on February 21, 2025, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the Issuer performance condition.

16. These dividend equivalent rights accrued on the 2020-1 PBRSUs. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2020-1 PBRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2020-1 PBRSUs to which they relate.

17. The shares reported represent an award of performance based restricted share units ("2020-2 PBRSUs") granted to the Reporting Person. The 2020-2 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest 100% on February 21, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the Issuer performance condition.

18. These dividend equivalent rights accrued on the 2020-2 PBRSUs. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2020-2 PBRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2020-2 PBRSUs to which they relate.

Remarks:

	/s/ Michele Keusch, as Attorney-in-Fact for Sami A. Siddiqui	01/07/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.